Update on The CRISPR IP Saga - Still Far from The Final Chapter

Presented by

Dr Claire Irvine (HGF Ltd), Sarah Morgan (Life Sciences IP Review)

About this talk

CRISPR gene-editing continues to hit the headlines regularly as a ground-breaking technology with many millions now flowing into companies seeking to exploit the technology in both the therapeutic and agricultural fields. Unfortunately, the IP landscape continues to lack clarity with possibility of divergence between Europe and the US. This webinar is aimed at those wishing to hear about the latest developments in the CRISPR IP landscape whether in the commercial, academic, legal or patent world. With the CRISPR IP saga seemingly not close to the final chapter, it will also provide an opportunity to raise questions which may arise from the on–going lack of clarity.
Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (73)
Subscribers (10998)
Content for the home of World IP Review and Life Sciences IP Review